Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axis

Wenxia Li1, Xuejiao Yin2, Hangjie Fu3

  • 1Hangzhou Innovation Institute, Beihang University, Hangzhou, Zhejiang, PR China; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.

Abstract

Insights

Eclipta prostrata extract induces cell death in multiple myeloma by triggering ferroptosis via the Keap1/Nrf2/HO-1 pathway. This traditional Chinese medicine shows promise for treating this incurable blood cancer.

Area of Science:

  • Hematological Malignancies
  • Traditional Chinese Medicine
  • Cancer Biology

Background:

  • Multiple myeloma (MM) is an incurable hematological malignancy with limited treatment options.
  • Eclipta prostrata, a traditional Chinese medicinal plant, exhibits known antitumor properties.
  • The therapeutic potential of E. prostrata in multiple myeloma remains unexplored.

Purpose of the Study:

  • To elucidate the mechanism by which the ethanol extract of E. prostrata (EEEP) exerts therapeutic effects in multiple myeloma.
  • To identify the key active components within EEEP responsible for its anti-myeloma activity.

Main Methods:

  • Investigated the pro-ferroptotic effects of EEEP on MM cell lines (RPMI-8226, U266), assessing cell death, proliferation, iron accumulation, and lipid peroxidation.
  • Analyzed the expression of key proteins in the Keap1/Nrf2/HO-1 pathway (Nrf2, Keap1, HO-1, GPX4) using western blotting.
  • Evaluated the in vivo efficacy of EEEP in MM xenograft mouse models and identified major constituents using HPLC and UPLC-Q/TOF-MS.

Main Results:

  • EEEP demonstrated significant inhibition of MM cell growth and induced cell death both in vitro and in vivo.
  • EEEP triggered ferroptosis in MM cells by promoting lipid peroxidation, malondialdehyde, and Fe2+ accumulation, alongside GSH suppression.
  • EEEP modulated the Keap1/Nrf2/HO-1 axis, with its effects on lipid peroxidation and malondialdehyde accumulation being reversed by Nrf2 activation.

Conclusions:

  • EEEP effectively inhibits multiple myeloma growth and induces cell death through ferroptosis, mediated by the Keap1/Nrf2/HO-1 pathway.
  • Key identified components of EEEP, including demethylwedelolactone and wedelolactone, are likely responsible for its anti-myeloma effects.
  • This study highlights EEEP as a novel therapeutic candidate for multiple myeloma, acting via a distinct ferroptosis regulatory axis.